Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin

Timothy H. Moran, Anne R. Baldessarini, Cynthia F. Salorio, Terese Lowery, Gary J. Schwartz

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To assess the role of subdiaphragmatic vagal afferent and efferent fibers in the mediation of the inhibition of food intake by cholecystokinin (CCK), we compared the ability of a dose range (1-16 ug/kg) of CCK to affect 30-min liquid glucose (0.125 g/ml) intake in rats with either total subdiaphragmatic vagotomy, selective subdiaphragmatic vagal deafferentation, selective subdiaphragmatic vagal deefferentation, or sham surgery. Selective vagal deafferentation and deefferentations were produced by combinations of unilateral subdiaphragmatic vagotomy and contralateral afferent or efferent rootlet transaction as fibers enter the caudal medulla. CCK produced a dose-related suppression of glucose intake in sham animals, and this action was eliminated in rats with total subdiaphragmatic vagotomy. CCK suppression of intake was attenuated in rats with vagal deafferentation, such that there was a loss of sensitivity to CCK. Vagal deefferentation resulted in lower levels of baseline intake and a truncation of the feedinginhibitory actions of CCK. These data demonstrate that CCK's suppression of intake depends on actions of both vagal afferent and efferent fibers. We interpret these data as suggesting that 1) the actions of low doses of CCK depend on activation of vagal afferent CCK receptors and 2) the greater efficacy of higher CCK doses is the result of the potentiation of these vagal afferent actions due to local physiological gastrointestinal effects of the peptide that rely on vagal efferent input.

Original languageEnglish (US)
JournalAmerican Journal of Physiology
Volume272
Issue number4 PART 2
StatePublished - 1997
Externally publishedYes

Fingerprint

Cholecystokinin
Eating
Vagotomy
Cholecystokinin B Receptor
Glucose
Peptides

Keywords

  • Visceral afférents

ASJC Scopus subject areas

  • Physiology (medical)

Cite this

Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. / Moran, Timothy H.; Baldessarini, Anne R.; Salorio, Cynthia F.; Lowery, Terese; Schwartz, Gary J.

In: American Journal of Physiology, Vol. 272, No. 4 PART 2, 1997.

Research output: Contribution to journalArticle

Moran, Timothy H. ; Baldessarini, Anne R. ; Salorio, Cynthia F. ; Lowery, Terese ; Schwartz, Gary J. / Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. In: American Journal of Physiology. 1997 ; Vol. 272, No. 4 PART 2.
@article{3b96d115bee947019ac27786b6f14696,
title = "Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin",
abstract = "To assess the role of subdiaphragmatic vagal afferent and efferent fibers in the mediation of the inhibition of food intake by cholecystokinin (CCK), we compared the ability of a dose range (1-16 ug/kg) of CCK to affect 30-min liquid glucose (0.125 g/ml) intake in rats with either total subdiaphragmatic vagotomy, selective subdiaphragmatic vagal deafferentation, selective subdiaphragmatic vagal deefferentation, or sham surgery. Selective vagal deafferentation and deefferentations were produced by combinations of unilateral subdiaphragmatic vagotomy and contralateral afferent or efferent rootlet transaction as fibers enter the caudal medulla. CCK produced a dose-related suppression of glucose intake in sham animals, and this action was eliminated in rats with total subdiaphragmatic vagotomy. CCK suppression of intake was attenuated in rats with vagal deafferentation, such that there was a loss of sensitivity to CCK. Vagal deefferentation resulted in lower levels of baseline intake and a truncation of the feedinginhibitory actions of CCK. These data demonstrate that CCK's suppression of intake depends on actions of both vagal afferent and efferent fibers. We interpret these data as suggesting that 1) the actions of low doses of CCK depend on activation of vagal afferent CCK receptors and 2) the greater efficacy of higher CCK doses is the result of the potentiation of these vagal afferent actions due to local physiological gastrointestinal effects of the peptide that rely on vagal efferent input.",
keywords = "Visceral aff{\'e}rents",
author = "Moran, {Timothy H.} and Baldessarini, {Anne R.} and Salorio, {Cynthia F.} and Terese Lowery and Schwartz, {Gary J.}",
year = "1997",
language = "English (US)",
volume = "272",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 PART 2",

}

TY - JOUR

T1 - Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin

AU - Moran, Timothy H.

AU - Baldessarini, Anne R.

AU - Salorio, Cynthia F.

AU - Lowery, Terese

AU - Schwartz, Gary J.

PY - 1997

Y1 - 1997

N2 - To assess the role of subdiaphragmatic vagal afferent and efferent fibers in the mediation of the inhibition of food intake by cholecystokinin (CCK), we compared the ability of a dose range (1-16 ug/kg) of CCK to affect 30-min liquid glucose (0.125 g/ml) intake in rats with either total subdiaphragmatic vagotomy, selective subdiaphragmatic vagal deafferentation, selective subdiaphragmatic vagal deefferentation, or sham surgery. Selective vagal deafferentation and deefferentations were produced by combinations of unilateral subdiaphragmatic vagotomy and contralateral afferent or efferent rootlet transaction as fibers enter the caudal medulla. CCK produced a dose-related suppression of glucose intake in sham animals, and this action was eliminated in rats with total subdiaphragmatic vagotomy. CCK suppression of intake was attenuated in rats with vagal deafferentation, such that there was a loss of sensitivity to CCK. Vagal deefferentation resulted in lower levels of baseline intake and a truncation of the feedinginhibitory actions of CCK. These data demonstrate that CCK's suppression of intake depends on actions of both vagal afferent and efferent fibers. We interpret these data as suggesting that 1) the actions of low doses of CCK depend on activation of vagal afferent CCK receptors and 2) the greater efficacy of higher CCK doses is the result of the potentiation of these vagal afferent actions due to local physiological gastrointestinal effects of the peptide that rely on vagal efferent input.

AB - To assess the role of subdiaphragmatic vagal afferent and efferent fibers in the mediation of the inhibition of food intake by cholecystokinin (CCK), we compared the ability of a dose range (1-16 ug/kg) of CCK to affect 30-min liquid glucose (0.125 g/ml) intake in rats with either total subdiaphragmatic vagotomy, selective subdiaphragmatic vagal deafferentation, selective subdiaphragmatic vagal deefferentation, or sham surgery. Selective vagal deafferentation and deefferentations were produced by combinations of unilateral subdiaphragmatic vagotomy and contralateral afferent or efferent rootlet transaction as fibers enter the caudal medulla. CCK produced a dose-related suppression of glucose intake in sham animals, and this action was eliminated in rats with total subdiaphragmatic vagotomy. CCK suppression of intake was attenuated in rats with vagal deafferentation, such that there was a loss of sensitivity to CCK. Vagal deefferentation resulted in lower levels of baseline intake and a truncation of the feedinginhibitory actions of CCK. These data demonstrate that CCK's suppression of intake depends on actions of both vagal afferent and efferent fibers. We interpret these data as suggesting that 1) the actions of low doses of CCK depend on activation of vagal afferent CCK receptors and 2) the greater efficacy of higher CCK doses is the result of the potentiation of these vagal afferent actions due to local physiological gastrointestinal effects of the peptide that rely on vagal efferent input.

KW - Visceral afférents

UR - http://www.scopus.com/inward/record.url?scp=33745401329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745401329&partnerID=8YFLogxK

M3 - Article

VL - 272

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 4 PART 2

ER -